Angioma Serpiginoso Angioma Serpiginosum

Autor: JM López Bertrán, T Mosquera, AE Saponaro, MA Marini, A Mazzobel, JG Casas, F Vigovich

Publikováno v: Revista Argentina de Dermatología, Vol 92, Iss 2, Pp 00-00 (2011)

El angioma serpiginoso es una rara dermatosis adquirida de origen desconocido. El 90% de los casos ocurre en mujeres y se manifiesta en la infancia o en la adolescencia. Las lesiones consisten en máculas puntiformes, eritematosas o violáceas, con u

Externí odkaz: https://doaj.org/article/485b1f837f0444ad96999b5d3e344885

Histone Acetyl Transferase 1 Is Overexpressed in Poor Prognosis, High-grade Meningeal and Glial Brain Cancers: Immunohistochemical and Aptahistochemical Study.

Autor: Bargiela-Cuevas S; Cell Biology and Genetics, Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain., Marin M; Laboratory Medicine Department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain., Gabaldon-Ojeda M; Cell Biology and Genetics, Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain., Klett-Mingo JI; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Granado P; Cell Biology and Genetics, Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain.; Inari Biotech, S.L., Madrid, Spain., Sacristan S; Aptamer Group, Department Biochemistry-Research, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain., Esteban-Lasso A; Inari Biotech, S.L., Madrid, Spain., Casas JG; EORTC, Medical Department, Bruxelles, Belgium (JGC)., Martin ME; Aptamer Group, Department Biochemistry-Research, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain., González VMM; Aptamer Group, Department Biochemistry-Research, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain., Royuela M; Cell Biology and Genetics, Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain.; Tissue Engineering and Regenerative Medicine, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain., García-Tuñon I; Cell Biology and Genetics, Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain.; Tissue Engineering and Regenerative Medicine, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain., Ortega Núñez MA; Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Spain.; Tissue Engineering and Regenerative Medicine, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Cancer Registry and Pathology Department, Principe de Asturias University Hospital, Alcala de Henares, Spain., Lobo MDVT; Cell Biology and Genetics, Department of Biomedicine and Biotechnology, University of Alcalá, Alcalá de Henares, Spain.; Aptamer Group, Department Biochemistry-Research, Ramón y Cajal Institute of Sanitary Research, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Publikováno v: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [J Histochem Cytochem] 2024 Aug-Sep; Vol. 72 (8-9), pp. 585-599. Date of Electronic Publication: 2024 Aug 24.

Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America.

Autor: Schmerling RA; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico., Casas JG; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico., Cinat G; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico., Ospina FEG; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico., Kassuga LEBP; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico., Tlahuel JLM; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico., Mazzuoccolo LD; Rafael A. Schmerling, Beneficiência Portugesa de São Paulo, São Paulo; Luiza E.B.P. Kassuga, National Cancer Institute, Rio de Janeiro, Brazil; Jose G. Casas, Hospital Alemán de Buenos Aires; Gabriela Cinat, University of Buenos Aires; Luis Daniel Mazzuoccolo, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Fabio Ernesto Grosso Ospina, Centro Nacional de Oncología de Colombia, Bogotá, Colombia; and Jorge Luis Martinez Tlahuel, National Cancer Institute, Mexico City, Mexico.

Publikováno v: Journal of global oncology [J Glob Oncol] 2018 Jul; Vol. 4, pp. 1-11.

Papular Epidermal Nevus with Skyline Basal Cell Layer (PENS): Three New Cases and Review of the Literature.

Autor: Luna PC; Dermatology Department, Hospital Alemán, Buenos Aires, Argentina., Panizzardi AA; Dermatology Department, Hospital Alemán, Buenos Aires, Argentina., Martin CI; Dermatology Department, Hospital Alemán, Buenos Aires, Argentina., Vigovich F; Dermatology Department, Hospital Alemán, Buenos Aires, Argentina., Casas JG; Dermatology Department, Hospital Alemán, Buenos Aires, Argentina., Larralde M; Dermatology Department, Hospital Alemán, Buenos Aires, Argentina.

Publikováno v: Pediatric dermatology [Pediatr Dermatol] 2016 May; Vol. 33 (3), pp. 296-300. Date of Electronic Publication: 2016 Mar 04.

[Intravascular lymphoma: Report of one case].

Autor: Young P, Massa M, Finn BC, Fleire G, Stemmelin GR, Ruades A, Sutovsky D, Casas JG, Dezanzo P, Vigovich F, Bruetman JE

Publikováno v: Revista medica de Chile [Rev Med Chil] 2015 Aug; Vol. 143 (8), pp. 1076-80.